Biography and Research Information
OverviewAI-generated summary
Stephanie Rogers' research interests encompass multiple facets of health sciences, with a recent focus on the clinical management of adverse events associated with Talquetamab in patients diagnosed with relapsed or refractory Multiple Myeloma. Her work also addresses best practices for developing inpatient programs aimed at preventing falls in older adults after discharge. Rogers investigates the variability of Minimal Residual Disease (MRD) status and its impact on clinical outcomes in Multiple Myeloma, exploring its dependence on molecular subgroups defined by gene expression profiling. Her scholarship metrics include an h-index of 12, with 29 total publications and 550 total citations. She has collaborated with researchers such as Phillip Farmer, Hira Imad Cheema, Trilok Shrivastava, and Manozna Karri, all from the University of Arkansas for Medical Sciences, with whom she has shared one publication each.
Metrics
- h-index: 12
- Publications: 29
- Citations: 555
Selected Publications
-
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)
-
Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma (2024)
Collaboration Network
Top Collaborators
Yara K. Haddad
1 shared publication
- CDC STEADI : Best practices for developing an inpatient program to prevent older adult falls after discharge
Jaswinder K. Legha
1 shared publication
- CDC STEADI : Best practices for developing an inpatient program to prevent older adult falls after discharge
Daphne Stannard
1 shared publication
- CDC STEADI : Best practices for developing an inpatient program to prevent older adult falls after discharge
Andrew Auerbach
1 shared publication
- CDC STEADI : Best practices for developing an inpatient program to prevent older adult falls after discharge
Elizabeth Eckstrom
1 shared publication
- CDC STEADI : Best practices for developing an inpatient program to prevent older adult falls after discharge
Donna Catamero
Mount Sinai Health System (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Chloe Ray
Mount Sinai Health System (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Kiah Purcell
Mount Sinai Health System (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Sheryl Leahey
City of Hope (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Elaine Esler
University of California, San Francisco (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Kayla Hefner
University of Arkansas for Medical Sciences
1 shared publication
In database
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Lisa O’Rourke
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Kathleen Gray
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Jaszianne Tolbert
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Thomas Renaud
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Similar Researchers
Based on overlapping research topics
Delgado-Calle Jesus
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Health Sciences Research and Education
B Barlogie
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Health Sciences Research and Education
Manuel Heredia
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Cancer Treatment and Pharmacology
Pamela Laborde
University of Arkansas for Medical Sciences
Geriatric Care and Nursing Homes
Health Sciences Research and Education
Health disparities and outcomes
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Cancer Treatment and Pharmacology
Manojna Konda
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Cancer Treatment and Pharmacology